Breaking News Instant updates and real-time market news.

NCLH

Norwegian Cruise Line

$54.87

0.19 (0.35%)

, SEAS

SeaWorld

$13.84

0.21 (1.54%)

08:45
01/08/18
01/08
08:45
01/08/18
08:45

Norwegian Cruise Line added to Select List, SeaWorld called a top pick at Stifel

Stifel analyst Steven Wieczynski named SeaWorld (SEAS) as his top overall pick in Gaming and Leisure for 2018, citing signs of improvement in its core operating fundamentals and a "compelling" relative valuation. He raised his price target on SeaWorld shares to $17 from $15. He also called Norwegian Cruise Line (NCLH) and Las Vegas Sands (LVS) top ideas for 2018, raising his price target on Las Vegas Sands to $476 from $72 and adding Norwegian to the firm's Select List.

NCLH

Norwegian Cruise Line

$54.87

0.19 (0.35%)

SEAS

SeaWorld

$13.84

0.21 (1.54%)

LVS

Las Vegas Sands

$67.92

-0.23 (-0.34%)

  • 08

    Jan

NCLH Norwegian Cruise Line
$54.87

0.19 (0.35%)

11/10/17
STFL
11/10/17
NO CHANGE
STFL
Buy
Stifel says buy cruise line stocks amid tax reform jitter weakness
Stifel analyst Steven Wieczynski attributes today's weakness in cruise line stocks to the fact that the recently released Senate tax reform bill has specific cruise language in it. However, he reminds investors that the initial House tax reform bill also had cruise specific language in it and "all of a sudden it disappeared," which is what he expect to happen in the Senate as well given the industry's lobbying power. He would use today's weakness in shares of Carnival (CCL), Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH) as a buying opportunity.
12/04/17
STFL
12/04/17
NO CHANGE
STFL
Buy
Cruise stocks should perform well today with tax overhang removed, says Stifel
After the Senate's final tax bill had no specific cruise language in it, Stifel analyst Steven Wieczynski said he expects cruise operators' stocks to perform well today with this overhang now removed. The firm maintains Buy ratings on Carnival (CCL), Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH).
11/30/17
MACQ
11/30/17
DOWNGRADE
Target $47
MACQ
Underperform
Norwegian Cruise Line downgraded to Underperform from Neutral at Macquarie
Macquarie analyst Matthew Brooks downgraded Norwegian Cruise Line (NCLH) to Underperform and cut its price target to $47 from $58. The analyst believes Carnival's (CCL) resurgence in capacity growth will drive yield pressure at Norwegian and thinks its higher leverage is a risk in a Fed tightening cycle. Brooks believes the Street is to optimistic on gross yield forecasts for Norwegian given the tough comp on pricing in 2018 and the start of Carnival's next wave of capacity growth.
11/30/17
11/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Gap (GPS) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez saying the risk/reward is skewed to the downside with the stock up nearly 40% over the past three months. 2. Royal Caribbean (RCL) was downgraded to Neutral from Outperform at Macquarie, while Norwegian Cruise Line (NCLH) was downgraded to Underperform from Neutral. 3. Dentsply Sirona (XRAY) downgraded to Neutral from Buy at H.C. Wainwright with analyst Raghuram Selvaraju citing valuation with the stock above his unchanged $68 price target. 4. Fibria Celulose (FBR) downgraded to Hold from Buy at Santander. 5. Mizuho Financial (MFG) downgraded to Equal Weight from Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SEAS SeaWorld
$13.84

0.21 (1.54%)

08/09/17
STFL
08/09/17
NO CHANGE
STFL
'Many' SeaWorld initiatives seem to be ' working,' says Stifel
Stifel analyst Steven Wieczynski says that calling SeaWorld's Q2 results disappointing "would be an understatement." However, the analyst says that "many of the company's "strategic initiatives" appear to be "working," and he says the stock remains attractive at current levels. The analyst cut his price target to $16 from $23 but keeps a Buy rating on the shares.
08/30/17
KEYB
08/30/17
INITIATION
KEYB
Sector Weight
SeaWorld resumed with a Sector Weight from Overweight at KeyBanc
KeyBanc analyst Brett Andress resumed coverage of SeaWorld with a Sector weight rating. The firm previously had an Overweight rating on the name.
09/15/17
SBSH
09/15/17
NO CHANGE
Target $14
SBSH
Neutral
Citi now sees Busch Gardens sale as more likely for SeaWorld
Citi analyst Jason Bazinet raised his probability of a Busch Gardens asset sale for SeaWorld Entertainment to 65% from 30%. He sees $2 of upside for the shares in the event of a sale. The company's lower EBITDA forecast suggests debt covenants may move to the forefront, Bazinet tells investors in a research note. He adds that press reports suggest Merlin Entertainment is interested in the parks. The analyst, however, reduced his price target for SeaWorld shares to $14 from $15. This reflects his new $12 per share standalone valuation for the company as well as $2 for a potential Busch Gardens sale. Bazinet keeps a Neutral rating on SeaWorld.
10/05/17
RHCO
10/05/17
NO CHANGE
RHCO
SeaWorld combination with Merlin 'could make sense,' says SunTrust
After Bloomberg reported that Merlin Entertainments had spoken with SeaWorld about a potential sale of its park assets, SunTrust analyst Michael A. Swartz says that such a deal "could make sense." The analyst says that the deal could be logical because both companies have assets in Southern California and Florida and have a customer base dominated by families with young children. He adds that Merlin has "a stronger balance sheet" and "a track record" of making acquisitions in the space, and he believes that a deal could enable the companies to compete more effectively against the larger players in their markets. But he believes the two investors who own roughly a combined 35% of SeaWorld's outstanding shares could prevent a transaction. The analyst keeps a $16 price target and a Buy rating on SeaWorld.
LVS Las Vegas Sands
$67.92

-0.23 (-0.34%)

12/07/17
LEHM
12/07/17
NO CHANGE
Target $75
LEHM
Overweight
Las Vegas Sands price target raised to $75 from $69 at Barclays
Barclays analyst Felicia Hendrix raised her price target for Las Vegas Sands to $75 after the company presented at his firm's conference. The company remains optimistic that mass gaming will drive Macau's growth for the long term, Hendrix tells investors in a research note. To reflect faster than expected market gross gaming revenue growth, the analyst raised her Q4 Macau EBITDA estimate. Hendrix keeps an Overweight rating on the shares.
11/22/17
UBSW
11/22/17
NO CHANGE
UBSW
UBS raises Macau estimates after positive survey
UBS analyst Robin Farley said the firm's proprietary Macau survey suggests better than expected junket trends and a further increase in VIP capacity, with higher end mass gaming revenue outpacing low end mass. The analyst raised estimates on the Macau gaming companies, noting that she prefers Wynn (WYNN) and Melco Resorts & Entertainment (MLCO) shares.
11/07/17
11/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Under Armour (UAA, UA) upgraded to Neutral from Negative at Susquehanna with analyst Sam Poser saying his downside thesis has played out. He now believes the downside is limited and the bar may have been set low enough to hit the reset button, although business will be challenging for some time. Poser lowered his price target to $11 from $15 on Under Armour shares. 2. Michael Kors (KORS) upgraded to Neutral from Sell at MKM Partners with analyst Roxanne Meyer saying the latest second quarter earnings show that the company has delivered on its strategies, reporting better first-half comps and improved gross margins. 3. AutoWeb (AUTO) upgraded to Outperform from Market Perform at Barrington with analyst Gary Prestopino saying he believes management has stabilized the business after its third quarter results were in-line and guidance for 2017 was maintained. 4. Las Vegas Sands (LVS) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Thomas Allen saying he now expects Macau gaming revenue to grow at a 10% compound annual growth rate through 2022 given China's transition to a high income economy, continued development and improving infrastructure. 5. Booz Allen (BAH) upgraded to Buy from Hold at Jefferies with analyst Sheila Kahyaoglu saying she views the post-earnings pullback in the shares as a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/18
DBAB
01/04/18
NO CHANGE
Target $183
DBAB
Buy
Deutsches says Wynn Resorts 'the one to buy' in Gaming
Deutsche Bank analyst Carlo Santarelli raised his price target for Wynn Resorts (WYNN) to $183 from $170 and says the stock is the "one to buy" in Gaming. The analyst believes "late cycle dynamics could become clearer" in 2018 regarding Las Vegas trends and he prefers to play the "hot hand." He thinks Wynn can outperform and keeps a Buy rating on the shares. Santarelli also raised his price target for Hold-rated MGM Resorts (MGM) to $38 from $37 and for Hold-rated Las Vegas Sands (LVS) to $65 from $63.

TODAY'S FREE FLY STORIES

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.